Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid.

Publication Type:

Journal Article


Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, Volume 21, Issue 12, p.3497-507 (2013)


2013, Adult, Aged, Aged, 80 and over, Analgesics, Antibodies, Monoclonal, Humanized, Bone Density Conservation Agents, Bone Neoplasms, Breast Neoplasms, Center-Authored Paper, Diphosphonates, Double-Blind Method, Female, Humans, Imidazoles, July 2014, Male, Middle Aged, Neoplasms, Pain, Prostatic Neoplasms, Castration-Resistant, Public Health Sciences Division, Quality of Life, Young Adult


This analysis evaluated patient-reported outcomes and analgesic use in patients with bone metastases from solid tumours across three comparative studies of denosumab and zoledronic acid.